Compare · 2 funds side by side · dividends reinvested

UPRO and CURE

UPROProShares×CUREDirexion×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$21,525UPRO · best of the two

02 / 04

UPRO and CURE, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

ProShares - UltraPro S&P500Leveraged · 3x0.88%0.81%+22.1%+20.1%+58.9%+16.6%−26.8%38.2%$5.2B1.3

Direxion Daily Healthcare Bull 3X ETFLeveraged · 3x0.94%0.76%+49.8%+82.5%+31.0%+7.8%−31.1%48.0%$200M1.8

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: UPRO 2009 · CURE 2011

Head to Head

Swap sides Versus in desk

Head to Head

ProShares - UltraPro S&P500 · $5.2B$21,525

UPRO

CURE

Direxion Daily Healthcare Bull 3X ETF · $200M$14,551

$10,000 five years ago, dividends reinvested · they hold 5.3% in common

UPROMeasureCURE

+22.1%Year to dateJan 1 → Nov 3+49.8%

+20.1%1 yearTotal return+82.5%

+58.9%3 years · per year$10,000 became $40,152 · $22,495+31.0%

+16.6%5 years · per year$10,000 became $21,525 · $14,551+7.8%

0.88%Expense ratio$88 · $94 a year on $10k · lower is better0.94%

0.81%Trailing 12-mo yield$81 · $76 a year on $10k0.76%

−26.8%Worst dropSmaller is better−31.1%

38.2%VolatilityLower is calmer48.0%

UPROCURE Winner of the row, in its colourEach row: the bigger of the two fills its side

6–2UPRO wins

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

UPRO vs CURE: Top 5 Holdings

Today

UPRO

34.5%in top 5

CURE

in top 59.4%

UPROStockCURE

21.7%IQMMnot top 5

3.9%AAPLnot top 5

3.9%NVDAnot top 5

not top 5LLY3.5%

3.0%MSFTnot top 5

not top 5JNJ2.0%

1.9%AMZNnot top 5

not top 5ABBV1.6%

not top 5MRK1.1%

not top 5UNH1.1%

Held in common5.3%

End-of-day Nov 3, 2026 · share of each fund

UPRO vs CURE Returns, Every Period

ProSharesUPRO

+16.6%

5 years, per year

CUREDirexion

+7.8%

5 years, per year

UPROCUREFaded: behind in that period

2–2Level

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

UPRO vs CURE

YTD

ProSharesUPRO

+22.1%

CUREDirexion

+49.8%

+22.1%Year to date+49.8%

−26.8%Worst drop · 1Y−31.1%

38.2%Volatility · 1Y48.0%

0.8%Yield0.8%

$5.2BAssets$200M

2–1UPRO wins

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: UPRO, CURE

Today

0.88%lowest, UPRO

FundExpense ratioFee$10k

UPRO0.88%$88

CURE0.94%$94

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: UPRO, CURE

0.81%highest, UPRO

FundTrailing yieldYield$10k

UPRO0.81%$81

CURE0.76%$76

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

−$7most kept, UPRO

UPRO$81 − $88 = −$7

CURE$76 − $94 = −$18

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: UPRO, CURE

Today

5.3%most shared, UPRO and CURE

UPROCURE

UPRO—5.3%

CURE5.3%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+82.5%CURE, at 48.0% volatility

UPROWorst drop−26.8%38.2% vol

CUREWorst drop−31.1%48.0% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

UPROCURE

+22.1%Year to date+49.8%

0.8%Yield0.8%

+20.1%Past year+82.5%

0.88%Fee0.94%

2–1CURE wins

End-of-day Nov 3, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.5%

JEPIJ.P. Morgan

+7.0%

+7.5%Year to date+7.0%

12.3%Yield8.0%

$41.8BAssets$46.0B

2–0JEPQ wins

End-of-day Nov 3, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026